Oral anticoagulant use in cardiovascular disorders: a perspective on present and potential indications for rivaroxaban.
CONCLUSION: NOACs may provide alternative treatment options in areas of unmet need, and numerous studies are underway to assess their benefit-risk profiles in these settings.
PMID: 29672182 [PubMed - as supplied by publisher]
Source: Current Medical Research and Opinion - Category: Research Tags: Curr Med Res Opin Source Type: research
More News: Angioplasty | Atrial Fibrillation | Cardiology | Cardiovascular | Clinical Trials | Coronary Angioplasty | Heart | Percutaneous Coronary Intervention | Peripheral Vascular Disease (PVD) | Pradaxa | Research | Stroke | Study | Thrombosis